Altered distribution of Fcγ receptor IIIA alleles in a cohort of Korean patients with lupus nephritis

Arthritis and Rheumatism

Volumn 42, Issue 4, 1999, Pages 818-823

  Salmon, Jane E ^a   Ng, Sonia ^a   Yoo, Dae Hyun ^b   Kim, Tae Hwan ^b   Kim, Seong Yoon ^b   Song, Gwan Gyu ^c  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b Hanyang University College of Medicine   (South Korea)

^c Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR;

ALLELE; ARTICLE; DISEASE SEVERITY; GENETIC RISK; GENOTYPE; HOMOZYGOSITY; HUMAN; INCIDENCE; KOREA; LUPUS ERYTHEMATOSUS NEPHRITIS; PREVALENCE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; ASIAN; CHEMISTRY; COHORT ANALYSIS; ETHNOLOGY; GENETICS; MONONUCLEAR CELL;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; GENOTYPE; HUMANS; INCIDENCE; KOREA; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; PREVALENCE; RECEPTORS, IGG;

EID: 0032588691     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199904)42:4<818::aid-anr28>3.0.co;2-j     Document Type: Article

References (12)

1. Salmon JE, Edberg JC, Brogle NL, Kimberly RP. Allelic polymorphisms of human Fcγ receptor IIA and Fey receptor IIIB: independent mechanisms for differences in human phagocyte function. J Clin Invest 1992;89:1274-81.
2. Haseley LA, Wisnieski JJ, Denburg MR, Michael-Grossman AR, Ginzler EM, Gourley MF, et al. Antibodies to C1q in systemic lupus erythematosus: characteristics and relation to Fc-γRIIA alleles. Kidney Int 1997;52:1375-80.
3. Salmon JE, Millard SS, Schachter LA, Arnett FC, Ginzler EM, Gourley MF, et al. FcγRIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 1996;97:1348-54.
4. Duits AJ, Bootsma H, Derksen RHWM, Spronk PE, Kater L, Kallenberg CGM, et al. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum 1996;39:1832-6.
5. Botto M, Theodorisdis E, Thompson EM, Beynon HL, Briggs D, Isenberg DA, et al. FcyRIIa polymorphism in systemic lupus erythematosus: no association with disease. Clin Exp Immunol 1996;104:264-8.
6. Manger K, Repp R, Spriewald BM, Rascu A, Geiger A, Wassmuth R, et al. Fcγ receptor IIa polymorphism in Caucasian patients with systemic lupus erythematosus: association with clinical symptoms. Arthritis Rheum 1998;41:1181-9.
7. Osborne JM, Chacko GW, Brandt JT, Anderson CL Ethnic variation in frequency of an allelic polymorphism of human FcγRIIA determined with allele specific oligonucleotide probes. J Immunol Methods 1994;173:207-17.
8. Song YW, Han C-W, Kang S-W, Baek H-J, Lee E-B, Shin C-H, et al. Abnormal distribution of Fcγ receptor type IIa polymorphism in Korean patients with systemic lupus erythematosus. Arthritis Rheum 1998;41:421-6.
9. Winkler TH, Henschek TA, Kalies I, Baenkler HW, Skvaril F, Kalden JR. Constant isotype patterns of anti-dsDNA antibodies in patients with systemic lupus erythematosus. Clin Exp Immunol 1988;72:434-9.
10. Ward J, Brenneman G, Letson GW, Heyward WL. Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska native infants. N Engl J Med 1990;323:1393-401.
11. Wu J, Edberg JC, Redecha PB, Bansal V, Guyre PM, Coleman K, et al. A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 1997;100:1059-70.
12. Koene HR, Kleijer M, Algra J, Roos D, von dem Borne AE, de Haas M. FcγRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell FcγRIIIa, independently of the FcγRIIIa-48L/R/H phenotype. Blood 1997;90:1109-14.